open access

Vol 2, No 3 (2001): Practical Diabetology
Research paper
Submitted: 2012-01-02
Published online: 2001-06-15
Get Citation

Assessment of coronary blood flow with the use of single photon emission computer tomography (SPECT) in young patients with type 1

Dariusz Naskręt, Dorota Zozulińska, Robert Oleksa, Anna Nowicka, Jerzy Sowiński, Michał Wierzchowiecki, Bogna Wierusz-Wysocka
Diabetologia Praktyczna 2001;2(3):195-202.

open access

Vol 2, No 3 (2001): Practical Diabetology
Original articles
Submitted: 2012-01-02
Published online: 2001-06-15

Abstract

OBJECTIVE. Long history of diabetes and persistant positive microalbuminuria significantly increase the risk of cardio-vascular complications. Detection of patients with vascular changes before their clinical manifestation with the use of sensitive and specific diagnostic procedures might lead to decrease in early mortality from coronary heart disease in this group of patients. AIM OF STUDY. Was to evaluate the coronary blood flow with the use of single photon emission computer tomography (SPECT) in young patients, with diabetic history longer than 5 years, negative towards circulatory diseases, negative ECG exercise test, negative or persistant positive microalbuminuria.
RESEARCH DESING. The study was entered by 8 patients with positive microalbuminuria (5 female, 3 male; aged 26,8 ± 4,7 years, diabetic history 15,8 ± ± 4,9 years and HbA1C 8,3 ± 2,3%) and 12 patients with negative microalbuminuria (9 female, 3 male; aged 26,4 ± 6,7 years, diabetic history 13,0 ± 3,9 years and HbA1C 8,8 ± 1,8%).
MATERIAL AND METHODS. Myocardial perfusion was examined by single photon emission computer tomography (SPECT) with gamma-camera (Siemens) with the system ICON 6.0.3. The study was performed at rest and during ischaemia induced pharmacologically with dipiridamol (0.56 mg/kg body weight). We used MIBI (methoxy-isobutyl-isonitrile) marked with 99mTc in dose 2 x 20 mCi. Selected parameters of heart rate variability (SNN50, SDNN, RMSSD, trianale index) were also compared. RESULTS. In the SPECT analysis we observed significant changes in radioactivity after dipiridamol in 6 patients with positive microalbuminuria (75,0%) and in 2 patients without microalbuminuria (17,0%). The assessed parameters of heart rate variability did not show any significant differences (p > 0,05). Myocardial perfusion changes coexisted with diabetic retinopathy in 88% patients with positive microalbuminuria and in 100% with negative microalbuminuria.
CONCLUSIONS.
1. Most patients with type 1 diabetes and positive microalbuminuria show significant, yet asymptomatic changes in myocardial blood flow.
2. Microalbuminuria appears as good early indicator of coronary heart disease in diabetic patients.
3. Diabetic retinopathy suggests presence changes of myocardial perfusion.
4. Patients with type 1 diabetic history longer than 5 years and microangipathy need an earlier and precise cardiological assessment

Abstract

OBJECTIVE. Long history of diabetes and persistant positive microalbuminuria significantly increase the risk of cardio-vascular complications. Detection of patients with vascular changes before their clinical manifestation with the use of sensitive and specific diagnostic procedures might lead to decrease in early mortality from coronary heart disease in this group of patients. AIM OF STUDY. Was to evaluate the coronary blood flow with the use of single photon emission computer tomography (SPECT) in young patients, with diabetic history longer than 5 years, negative towards circulatory diseases, negative ECG exercise test, negative or persistant positive microalbuminuria.
RESEARCH DESING. The study was entered by 8 patients with positive microalbuminuria (5 female, 3 male; aged 26,8 ± 4,7 years, diabetic history 15,8 ± ± 4,9 years and HbA1C 8,3 ± 2,3%) and 12 patients with negative microalbuminuria (9 female, 3 male; aged 26,4 ± 6,7 years, diabetic history 13,0 ± 3,9 years and HbA1C 8,8 ± 1,8%).
MATERIAL AND METHODS. Myocardial perfusion was examined by single photon emission computer tomography (SPECT) with gamma-camera (Siemens) with the system ICON 6.0.3. The study was performed at rest and during ischaemia induced pharmacologically with dipiridamol (0.56 mg/kg body weight). We used MIBI (methoxy-isobutyl-isonitrile) marked with 99mTc in dose 2 x 20 mCi. Selected parameters of heart rate variability (SNN50, SDNN, RMSSD, trianale index) were also compared. RESULTS. In the SPECT analysis we observed significant changes in radioactivity after dipiridamol in 6 patients with positive microalbuminuria (75,0%) and in 2 patients without microalbuminuria (17,0%). The assessed parameters of heart rate variability did not show any significant differences (p > 0,05). Myocardial perfusion changes coexisted with diabetic retinopathy in 88% patients with positive microalbuminuria and in 100% with negative microalbuminuria.
CONCLUSIONS.
1. Most patients with type 1 diabetes and positive microalbuminuria show significant, yet asymptomatic changes in myocardial blood flow.
2. Microalbuminuria appears as good early indicator of coronary heart disease in diabetic patients.
3. Diabetic retinopathy suggests presence changes of myocardial perfusion.
4. Patients with type 1 diabetic history longer than 5 years and microangipathy need an earlier and precise cardiological assessment
Get Citation

Keywords

type 1 diabetes; coronary heart desease; microalbuminuria; single photon emission computer tomography (SPECT)

About this article
Title

Assessment of coronary blood flow with the use of single photon emission computer tomography (SPECT) in young patients with type 1

Journal

Clinical Diabetology

Issue

Vol 2, No 3 (2001): Practical Diabetology

Article type

Research paper

Pages

195-202

Published online

2001-06-15

Page views

493

Article views/downloads

1776

Bibliographic record

Diabetologia Praktyczna 2001;2(3):195-202.

Keywords

type 1 diabetes
coronary heart desease
microalbuminuria
single photon emission computer tomography (SPECT)

Authors

Dariusz Naskręt
Dorota Zozulińska
Robert Oleksa
Anna Nowicka
Jerzy Sowiński
Michał Wierzchowiecki
Bogna Wierusz-Wysocka

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl